FAJTX | RBEMX | FAJTX / RBEMX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 11 years | 11 years | - |
Gain YTD | 2.779 | 2.738 | 102% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 25.3B | 25.3B | 100% |
Annual Yield % from dividends | 1.07 | 0.76 | 141% |
Returns for 1 year | 10.70 | 10.17 | 105% |
Returns for 3 years | 14.00 | 12.87 | 109% |
Returns for 5 years | 40.34 | 38.10 | 106% |
Returns for 10 years | 70.19 | 65.92 | 106% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AGGNX | 14.74 | N/A | N/A |
American Century Global Gold I | |||
LOGSX | 21.00 | N/A | N/A |
Live Oak Health Sciences | |||
USLYX | 70.09 | N/A | N/A |
JHancock U.S. Global Leaders Growth R2 | |||
BGCJX | 14.84 | -0.12 | -0.80% |
Baillie Gifford EAFE Plus All Cap 3 | |||
MLAIX | 12.00 | -0.11 | -0.91% |
NYLI Winslow Large Cap Growth Class I |